MetLife Investment Management’s DOMTAR CORPORATION (New) UFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-17,900
Closed -$976K 2624
2021
Q3
$976K Hold
17,900
0.01% 1128
2021
Q2
$984K Sell
17,900
-31,747
-64% -$1.54M 0.01% 1170
2021
Q1
$1.83M Sell
49,647
-5,118
-9% -$177K 0.02% 902
2020
Q4
$1.73M Sell
54,765
-1,397
-2% -$39.8K 0.02% 897
2020
Q3
$1.48M Sell
56,162
-1,175
-2% -$29.7K 0.02% 856
2020
Q2
$1.21M Buy
57,337
+24,462
+74% +$531K 0.01% 949
2020
Q1
$711K Hold
32,875
0.01% 1044
2019
Q4
$1.26M Sell
32,875
-3,525
-10% -$131K 0.01% 979
2019
Q3
$1.3M Sell
36,400
-984
-3% -$36.5K 0.01% 953
2019
Q2
$1.66M Sell
37,384
-972
-3% -$44.4K 0.02% 888
2019
Q1
$1.9M Buy
38,356
+2
+0% +$95 0.02% 840
2018
Q4
$1.35M Sell
38,354
-152
-0.4% -$6.66K 0.02% 917
2018
Q3
$2.01M Sell
38,506
-983
-2% -$49.5K 0.02% 857
2018
Q2
$1.89M Buy
39,489
+365
+0.9% +$16.9K 0.02% 806
2018
Q1
$1.66M Sell
39,124
-543
-1% -$25.5K 0.02% 834
2017
Q4
$1.96M Buy
+39,667
New +$1.84M 0.02% 793

Other funds holding UFS

MetLife Investment Management's UFS Position: Q4 2021 in Review

MetLife Investment Management sold out of DOMTAR CORPORATION (New) (UFS) in Q4 2021, closing a stake of 17,900 shares — an estimated $976K sold.

MetLife Investment Management first reported a position in UFS in Q4 2017 and held it in 16 quarters. The position peaked at $2.01M in Q3 2018. 1 fund tracked by Wall St. Rank holds UFS as of Q4 2021.

  • MetLife Investment Management reported no remaining DOMTAR CORPORATION (New) position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 17,900 DOMTAR CORPORATION (New) shares in Q4 2021, an estimated $976K.
  • MetLife Investment Management first reported a position in DOMTAR CORPORATION (New) in Q4 2017 and held it in 16 quarters.
  • MetLife Investment Management's DOMTAR CORPORATION (New) position peaked at $2.01M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held DOMTAR CORPORATION (New) as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.